U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07121335) titled 'SMC Radiation Oncology SABR Cohort for Oligometastasis' on Aug. 04.
Brief Summary: The goal of this observational study is to evaluate the efficacy and safety of stereotactic body radiotherapy (SABR) in patients with oligometastatic or oligoprogressive cancer.
The main questions it aims to answer are:
1. oncologic outcomes (progression-free survival, local failure rate),
2. patient-reported outcomes,
3. physician-assessed toxicity, and
4. dynamics of circulating tumor DNA (ctDNA) for biomarker analysis.
Study Start Date: May 01
Study Type: OBSERVATIONAL
Condition:
Stereotactic Body Radiation Therapy (SBRT)
Oligometastasis
O...